The future of medicines
Mar 3, 2010
By Olle Torgny
Filed in Expressions
Since a long time, science knows that placebo is over 50% of the effect of medicines and drugs, including coffee. Still most products in this area rely on chemical performance.
This is my first example of how many product areas develop: initially focus on physical performance, then presentation and handling and after that experience and meaning. It all goes hand in hand with the established marketing and motivation theories*.

Typical modernistic medicine (above). Tasteful and practical packaging. This is what I mean by something that just “is”. A pill is a pill. The whole value is considered to be hidden in the substance. Your doctor will tell you what medicine to use. Cause-and-effect proven by science. Some branding effect in the well known name. But any additions of pictures, promises or other experience elements would actually be considered immoral, even if they might enhance the medical effect.
Then, of course, there is fair amount of credibility in this dry and simplistic presentation. But is it an active design choise, based on what gives the best experience and effect? I don’t think so.

French day and night pills for colds (above). User oriented presentation makes the use easier. Choise of colours and materials make the white pills look better. The presentation is more elegant and “selling”. But the pill is still a pill.

“Hollywood.” American cold medicine full of promises and experience. Large colourful box, large colourful capsules. Focus on the user experience and sense of value.
In Sweden we just recently dropped the monopoly of pharmacies. Soon we will be able to buy some medicines in supermarkets. Medicine will be increasingly treated as consumer products when people are to make their own choises off the shelf.
Is “Hollywood” medicine the next step? Or rather experience oriented, placebo-enhancing, simple to use and understand, value-added medicine?
*) Maslow, Herzberg, Peters/Waterman jr, Mayo, Levitt, Ries, Trout, Negroponte and most others…

